[Home ] [Archive]   [ فارسی ]  
Main Menu
Home::
Journal Information::
About the Journal
Aims & Scopes
Editorial Board
Indexing & Abstracting
Archive::
All Issues
Current Issue
For Authors::
Authors' Guide
Reference Guide
Authorship Criteria
Submit an Article
For Reviewers::
Reviewing Policy
Principles of Transparency::
Publication Ethics Statement
Research Ethics Statement
Open Access Statement
Copyright
Contact us::
::
Search in website

Advanced Search
..
Licenses

AWT IMAGE

Attribution-NonCommercial
CC BY-NC

AWT IMAGE

Open Access Publishing

AWT IMAGE

Prevent Plagiarism

AWT IMAGE
..
:: Volume 23, Issue 3 (2017) ::
Iran J Forensic Med 2017, 23(3): 190-196 Back to browse issues page
Investigation The Cause and Prevalence of Digoxin Poisoning in Cardiac Patients hospitalized in Firoozgar Hospital in Tehran Between 2011 and 2015
Abbas Aghabiklooei 1, Zahra Mousavi2 , Shiva Mahdizadeh3
1- Fellowship of Clinical Toxicology and Poisoning, Firoozgar Hospital, Tehran, Iran , aghabikloo@yahoo.com
2- Associate Professor of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3- MSc in Toxicology, University of Medical Sciences, Tehran, Iran
Abstract:   (19291 Views)

Background: Due to prescribing high doses of digoxin for cardiac patients and the importance of its poisoning, this study aimed to survey the correlation between prevalence of digoxin serum level with poisoning symptoms, determining the role of interventional factors such as underlying diseases, electrolyte and metabolic disorders in association with the occurrence of poisoning, determination of the prevalence of cardiac and non-chronic signs of chronic poisoning with digoxin in cardiac patients who receive digoxin.
Method: This was a cross sectional study which was conducted on 531 hospitalized patients using. Patient information including cardiac and non-cardiac symptoms, and laboratory findings, especially digoxin serum levels, were extracted from clinical records and analyzed statistically.
Findings: Poisoning prevalence with Digoxin in patients were 10% and 97.9% out of 52 patients with Digoxin poisoning, related to Chronic poisoning in patients treated with digoxin and only 2 cases were acute poisoning due to attempted suicide. 60% of patients were females and the mean age of patients was 78±11.3. The mean level of digoxin serum in male and female groups were 2.81±0.13 ng/ml and 2.94±0.07 ng/ml, respectively. There was a significant difference in the mean serum level of patients over 65 and under 65 years old (3.28 ± 0.14 ng/mL and 2.66 ± 0.09 ng/mL respectively). In 62% of patients, renal function enzymes were increased. Subacute renal disease or acute renal failure was the most important cause of digoxin poisoning.
Conclusion: The high age and subacute renal disease or acute renal failure are the most important factors in prediction of the occurrence probability of Digoxin poisoning in patients treated with this drug. The risk of poisoning increases up to 2 or 3 times for people over 65 years old.
Keywords: Poisoning, Digoxin, Cardiac patients
Full-Text [PDF 630 kb]   (3036 Downloads)    
Type of Article: Research Article | Subject: Forensic Medicine
Received: 2017/01/18 | Revised: 2018/04/18 | Accepted: 2018/02/25 | ePublished: 2018/02/25
References
1. Steiner JF, Robbins LJ, Hammermeister KE, Roth SC, Hammond WS . Incidence of digoxin toxicity in outpatients. The Western journal of medicine. 1994;161(5):474-8 [PMID] [PMCID]
2. Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y. Effect of aging on the incidence of digoxin toxicity. The Annals of pharmacotherapy. 2000;34(4):427-32 [DOI:10.1345/aph.19103] [PMID]
3. Hickey AR, Wenger TL, Carpenter VP, Tilson HH, Hlatky MA, Furberg CD, et al. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. Journal of the American College of Cardiology. 1991;17(3):590-8 [DOI:10.1016/S0735-1097(10)80170-6]
4. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. The New England journal of medicine. 2011;365(21):2002-12 [DOI:10.1056/NEJMsa1103053] [PMID]
5. Aarnoudse AL, Dieleman JP, Stricker BH. Age- and gender-specific incidence of hospitalisation for digoxin intoxication. Drug safety. 2007;30(5):431-6 [DOI:10.2165/00002018-200730050-00006] [PMID]
6. Mahdyoon H, Battilana G, Rosman H, Goldstein S, Gheorghiade M. The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. American heart journal. 1990;120(5):1189-94 [DOI:10.1016/0002-8703(90)90135-K]
7. Pita-Fernandez S, Lombardia-Cortina M, Orozco-Veltran D, Gil-Guillen V. Clinical manifestations of elderly patients with digitalis intoxication in the emergency department. Archives of gerontology and geriatrics. 2011;53(2):e106-10 [DOI:10.1016/j.archger.2010.07.003] [PMID]
8. Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD. Digitalis glycosides: mechanisms and manifestations of toxicity. Part III. Progress in cardiovascular diseases. 1984;27(1):21-56 [DOI:10.1016/0033-0620(84)90018-5]
9. Limon G, Ersoy G, Oray NC, Bayram B, Limon O. Retrospective evaluation of patients with elevated digoxin levels at an emergency department. Turkish journal of emergency medicine. 2016;16(1):17-21 [DOI:10.1016/j.tjem.2015.10.001] [PMID] [PMCID]
10. Marvin HM. Digitalis and diuretics in heart failure with regular rhythm, with special reference to importance of etiologic classification of heart disease. J Clin Invest. 1927;3(3):521–539 [DOI:10.1172/JCI100098] [PMID] [PMCID]
11. Wiggers CJ, Stimson B. Studies on the cardiodynamic actions of drugs III. The mechanism of cardiac stimulation by digitalis and g-strophanthin. J Pharmacol Exp Ther. 1927;30(3):251–269
12. Cattell M, Gold H. The influence of digitalis glucosides on the force of contraction of mammalian cardiac muscle. J Pharmacol Exp Ther. 1938;62(1):116–125
13. Bloomfield RA, Rapoport B, Milnor JP, Long WK, Mebane JG, Ellis LB, Lavin MR. The effects of the cardiac glycosides upon the dynamics of the circulation in congestive heart failure. I. Ouabain. J Clin Invest. 1948;27(5):588–599 [DOI:10.1172/JCI102004] [PMCID]
14. Selzer, A, Kelly, J. Action of digitalis upon the non-failing heart: A critical review. Prog Cardiovasc Dis. 1964;7(3):273–283 [DOI:10.1016/S0033-0620(64)80023-2]
15. Arnold SB, Byrd RC, Meister W, et al. Long-term digitalis therapy improves left ventricular function in heart failure. New Engl J Med. 1980;303(25):1443–1448 [DOI:10.1056/NEJM198012183032503] [PMID]
16. Eichhorn EJ, Willard JE, Alvarez L, et al. Are contraction and relaxation coupled in patients with and without congestive heart failure?. Circulation. 1992 (85):2132–2139 [DOI:10.1161/01.CIR.85.6.2132] [PMID]
17. Fleg L, Gottlieb SH, Lakatta EG. Is digoxin really important in compensated heart failure?. Am J Med. 1982(73): 244–250 [DOI:10.1016/0002-9343(82)90186-3]
18. Fleg JL, Rothfeld B, Gottlieb SH. Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease. A randomized placebo-controlled crossover trial. J Am Coll Cardiol. 1991(17):743–751 [DOI:10.1016/S0735-1097(10)80194-9]
19. German and Austrian Xamoterol study group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet. 1988 (1):489–493
20. Gheorghiade M, Beller G. Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol. 1983 (51):1243–1250 [DOI:10.1016/0002-9149(83)90293-X]
21. Johnston GC, McDevitt DG. Is maintenance digoxin necessary in patients with sinus rhythm?. Lancet. 1979 (i):567–570 [DOI:10.1016/S0140-6736(79)91002-X]
22. Hull SM, Mackintosh A. Discontinuation of maintenance digoxin therapy in general practice. Lancet. 1977 (47):1054–1055 [DOI:10.1016/S0140-6736(77)91886-4]
23. Smith TW, Antman EM, Friedman PL, et al. Digitalis glycosides: Mechanisms and manifestations of toxicity. Prog Cardiovasc Dis. 1984 (26):413–458 [DOI:10.1016/0033-0620(84)90012-4]
24. Smith TW, Haber E. Digoxin intoxication: The relationship of clinical presentation to serum digoxin concentration. J Clin Invest. 1970 (49):2377–2386 [DOI:10.1172/JCI106457] [PMID] [PMCID]
25. Beller GA, Smith TW, Abelmann WH, et al. Digitalis intoxication: A prospective clinical study with serum level correlations. N Engl J Med. 1971 (284):989–997 [DOI:10.1056/NEJM197105062841801] [PMID]
26. Gheorghiade M, Benatar D, Konstam MA, et al. Pharmacotherapy for systolic dysfunction: A review of randomized clinical trials. Am J Cardiol. 1997 (80):14H–27H [DOI:10.1016/S0002-9149(97)00816-3]
27. Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA. 1988 (259):539–544 [PMID]
28. Guyatt GH, Sullivan MJ, Fallen EL, et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol. 1988 (61):371–375 [DOI:10.1016/0002-9149(88)90947-2]
29. Haerer W, Bauer U, Hetzel M, et al. Long-term effects of digoxin and diuretics in congestive heart failure: Results of a placebo-controlled randomized double blind study. Circulation. 1988 (78):48–53
30. DiBianco R, Shabetai R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 (320):677–683 [DOI:10.1056/NEJM198903163201101] [PMID]
31. Van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, et al. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol. 1993;22(6):1564-73 [DOI:10.1016/0735-1097(93)90579-P]
32. Packer M, Gheorghiade M, Young JB, et al. For the RADIANCE Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med. 1993 (329):1–7 [DOI:10.1056/NEJM199307013290101] [PMID]
33. Hauptman PJ, Kelly RA. Digitalis. Circulation. 1999 (99):1265-1270
34. Gheorghiade M, Ferguson D. Digoxin: a neurohormonal modulator in heart failure? Circulation. 1991 (84):2181-218 [DOI:10.1161/01.CIR.84.5.2181] [PMID]
Send email to the article author

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aghabiklooei A, Mousavi Z, Mahdizadeh S. Investigation The Cause and Prevalence of Digoxin Poisoning in Cardiac Patients hospitalized in Firoozgar Hospital in Tehran Between 2011 and 2015. Iran J Forensic Med 2017; 23 (3) :190-196
URL: http://sjfm.ir/article-1-826-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 3 (2017) Back to browse issues page
مجله پزشکی قانونی ایران Iranian Journal of Forensic Medicine
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645